Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCHCD3)

ClinicalTrials.gov ID: NCT03244644

Public ClinicalTrials.gov record NCT03244644. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 10:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Prospective, Randomized, Double-blinded, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of RBX2660 (Microbiota Suspension) for the Prevention of Clostridium Difficile Infection

Study identification

NCT ID
NCT03244644
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Rebiotix Inc.
Industry
Enrollment
320 participants

Conditions and interventions

Interventions

  • RBX2660 Drug
  • Placebo Drug
  • Open label RBX2660 (only for confirmed CDI recurrence) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 30, 2017
Primary completion
Apr 1, 2020
Completion
Aug 2, 2020
Last update posted
Jul 9, 2024

2017 – 2020

United States locations

U.S. sites
60
U.S. states
35
U.S. cities
57
Facility City State ZIP Site status
Athens Athens Alabama 35611
Dothan Dothan Alabama 36305
Phoenix Phoenix Arizona 85054
North Little Rock North Little Rock Arkansas 72117
Lancaster Lancaster California 93534
Los Angeles Los Angeles California 90095
Oxnard Oxnard California 93030
Sacramento Sacramento California 95817
Aurora Aurora Colorado 80045
Hamden Hamden Connecticut 06518
Gainesville Gainesville Florida 32610
Jacksonville Jacksonville Florida 32224
Miami Miami Florida 33176
Port Orange Port Orange Florida 32127
Atlanta Atlanta Georgia 30322
Atlanta Atlanta Georgia 30342
Idaho Falls Idaho Falls Idaho 83404
Gurnee Gurnee Illinois 60031
Highland Park Highland Park Illinois 60035
Maywood Maywood Illinois 60153
Lafayette Lafayette Indiana 47904
Topeka Topeka Kansas 66606
Wichita Wichita Kansas 67214
Lexington Lexington Kentucky 40536
New Orleans New Orleans Louisiana 70121
Shreveport Shreveport Louisiana 71105
Boston Boston Massachusetts 02114
Detroit Detroit Michigan 48202
Plymouth Plymouth Minnesota 55446
Rochester Rochester Minnesota 55902
St. Louis St Louis Missouri 63110
Omaha Omaha Nebraska 68198-4031
Omaha Omaha Nebraska 68198
Las Vegas Las Vegas Nevada 89106
Teaneck Teaneck New Jersey 07666
New York New York New York 10016
North Massapequa North Massapequa New York 11758
Rochester Rochester New York 14618
Durham Durham North Carolina 27710
Greenville Greenville North Carolina 27834
Wilmington Wilmington North Carolina 28401
Fargo Fargo North Dakota 58102
Toledo Toledo Ohio 43608
Portland Portland Oregon 97701
Flourtown Flourtown Pennsylvania 19031
Philadelphia Philadelphia Pennsylvania 19102
Philadelphia Philadelphia Pennsylvania 19107-5244
Uniontown Uniontown Pennsylvania 15401
Wyomissing Wyomissing Pennsylvania 19610
Charleston Charleston South Carolina 29425
Rapid City Rapid City South Dakota 57701
Hixson Hixson Tennessee 37434
Dallas Dallas Texas 75246
Houston Houston Texas 77030
West Jordan West Jordan Utah 84088
Springfield Springfield Virginia 22150
Winchester Winchester Virginia 22601
Seattle Seattle Washington 98104
Madison Madison Wisconsin 53792
Marshfield Marshfield Wisconsin 54449

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03244644, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 9, 2024 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03244644 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →